Form 4: Xylem Inc. Director Jerome A. Peribere Reports Acquisition of Restricted Stock Units

Director Jerome A. Peribere reports acquisition of 1,156 restricted stock units and dividend reinvestment shares of Xylem Inc.

Summary

• Jerome A. Peribere, a director of Xylem Inc., filed a Form 4 on May 20, 2024, reporting a transaction on May 16, 2024.
• The transaction involved the acquisition of 1,156 shares of Common Stock as restricted stock units (RSUs) under the Xylem 2011 Omnibus Incentive Plan.
• These RSUs are scheduled to vest in full on the trading day prior to the 2025 Annual Meeting of Shareholders, with settlement deferred until separation from service.
• Additionally, the report indicates the acquisition of shares due to dividend reinvestment.
• Following the reported transactions, Peribere directly owns 4,570 shares and indirectly owns 24,160 shares through the Jerome A Peribere 2016 Revocable TR.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs and dividend reinvestment suggest confidence in the company's future, but it's a routine filing.

Positives

• The acquisition of restricted stock units aligns the director's interests with the long-term performance of the company.
• Dividend reinvestment indicates a continued investment in the company's stock.

Future Outlook

The restricted stock units are scheduled to vest in full on the trading day prior to the 2025 Annual Meeting of Shareholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates ongoing equity-based compensation for a director at Xylem Inc.

Comparison to Industry Standards

• Equity compensation is a common practice among publicly traded companies to align the interests of directors and executives with those of shareholders.
• Companies like Danaher, Roper Technologies, and Agilent Technologies also utilize similar equity-based compensation plans for their executives and directors.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates